SCHEDULE: ING Groep Discloses 3.99% Stake in NEOGEN Corp

ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have reported a shared beneficial ownership of 3.99% in NEOGEN Corp's common stock.

Summary

• ING Groep N.V. and its wholly-owned subsidiary, ING Capital Markets LLC, jointly reported beneficial ownership of 8,673,700 shares of NEOGEN Corp common stock.
• This represents approximately 3.99% of NEOGEN Corp's outstanding common stock.
• The ownership percentage is based on 217,298,626 shares of common stock outstanding as of August 31, 2025, as reported in NEOGEN's Quarterly Report on Form 10-Q filed on October 9, 2025.
• Both ING Groep N.V. and ING Capital Markets LLC hold shared voting power and shared dispositive power over all 8,673,700 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of NEOGEN Corp.

Sentiment

Score: 5

Explanation: This is a neutral, factual disclosure of institutional ownership, providing no explicit positive or negative sentiment regarding the issuer's performance or prospects.

Future Outlook

The filing, a Schedule 13G, is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding NEOGEN Corp's future outlook or performance.

Industry Context

This filing is a standard regulatory disclosure of institutional ownership, indicating a passive investment by a major financial institution. It does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which can contribute to market understanding of the company's investor base.
• Management: Awareness of a substantial, passive institutional holder in the company's common stock.

Key Dates

Keywords

NEOGEN Corp, ING Groep, ING Capital Markets, Schedule 13G, beneficial ownership, common stock, institutional ownership, SEC filing